Biofil Chemicals & Pharmaceuticals Limited (NSE:BIOFILCHEM) — Stock Price
Biofil Chemicals & Pharmaceuticals Limited (NSE:BIOFILCHEM) is currently trading at Rs32.64 INR, up 0.77% today. Over the past 52 weeks, shares have ranged between Rs25.79 and Rs46.34. This page tracks Biofil Chemicals & Pharmaceuticals Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Biofil Chemicals & Pharmaceuticals Limit (BIOFILCHEM) market capitalisation.
Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Biofil Chemicals & Pharmaceuticals Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Biofil Chemicals & Pharmaceuticals Limited Income Statement — Revenue, Profit & Earnings by Year
Biofil Chemicals & Pharmaceuticals Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Rs334.02 Million | Rs400.35 Million | Rs300.35 Million | Rs223.82 Million | Rs357.50 Million |
| Cost of Revenue | Rs313.11 Million | Rs375.07 Million | Rs274.72 Million | Rs195.16 Million | Rs324.82 Million |
| Gross Profit | Rs20.91 Million | Rs25.28 Million | Rs25.63 Million | Rs28.66 Million | Rs33.23 Million |
| Research & Development | — | — | — | — | Rs104.00K |
| SG&A | Rs4.16 Million | Rs1.40 Million | Rs1.36 Million | Rs1.88 Million | Rs1.77 Million |
| Total Operating Expenses | Rs16.24 Million | Rs21.11 Million | Rs18.73 Million | Rs20.17 Million | Rs21.36 Million |
| Operating Income | Rs4.68 Million | Rs4.17 Million | Rs7.39 Million | Rs9.05 Million | Rs11.87 Million |
| EBITDA | Rs11.53 Million | Rs13.06 Million | Rs12.65 Million | Rs14.83 Million | Rs23.99 Million |
| EBIT | Rs7.73 Million | Rs9.07 Million | Rs8.36 Million | Rs10.55 Million | Rs19.87 Million |
| Interest Expense | Rs369.00K | Rs415.00K | Rs425.00K | Rs406.00K | Rs681.00K |
| Income Before Tax | Rs7.36 Million | Rs8.65 Million | Rs7.93 Million | Rs10.15 Million | Rs19.19 Million |
| Income Tax Expense | Rs1.78 Million | Rs1.56 Million | Rs2.33 Million | Rs3.17 Million | Rs6.78 Million |
| Net Income | Rs5.58 Million | Rs7.09 Million | Rs5.60 Million | Rs6.98 Million | Rs12.41 Million |
Biofil Chemicals & Pharmaceuticals Limited Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Biofil Chemicals & Pharmaceuticals Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Rs509.60 Million | Rs470.83 Million | Rs314.06 Million | Rs187.32 Million | Rs332.38 Million |
| Total Current Assets | Rs425.54 Million | Rs384.08 Million | Rs223.54 Million | Rs93.13 Million | Rs234.62 Million |
| Cash & Equivalents | Rs1.32 Million | Rs22.84 Million | Rs260.00K | Rs1.45 Million | Rs4.41 Million |
| Short-term Investments | Rs1.23 Million | Rs21.91 Million | Rs117.00K | Rs600.00K | Rs4.31 Million |
| Net Receivables | Rs383.15 Million | Rs330.29 Million | Rs205.03 Million | Rs71.79 Million | Rs183.03 Million |
| Inventory | Rs33.41 Million | Rs25.50 Million | Rs12.13 Million | Rs12.93 Million | Rs43.45 Million |
| Property, Plant & Equipment | Rs83.45 Million | Rs86.24 Million | Rs90.01 Million | Rs94.19 Million | Rs97.77 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Rs321.79 Million | Rs288.80 Million | Rs141.04 Million | Rs18.95 Million | Rs171.09 Million |
| Total Current Liabilities | Rs318.48 Million | Rs285.25 Million | Rs137.25 Million | Rs14.95 Million | Rs167.53 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | Rs3.39 Million | Rs-18.45 Million | Rs4.85 Million | Rs3.20 Million | Rs-107.00K |
| Total Stockholder Equity | Rs187.82 Million | Rs182.03 Million | Rs173.01 Million | Rs168.38 Million | Rs161.29 Million |
| Retained Earnings | Rs-113.66 Million | Rs-316.94 Million | Rs-325.96 Million | Rs-330.60 Million | Rs-337.68 Million |
Biofil Chemicals & Pharmaceuticals Limited Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Biofil Chemicals & Pharmaceuticals Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs-19.24 Million | Rs23.94 Million | Rs-1.12 Million | Rs-2.20 Million | Rs11.11 Million |
| Capital Expenditures | Rs1.00 Million | Rs229.00K | Rs106.00K | Rs699.00K | Rs5.67 Million |
| Free Cash Flow | Rs-20.24 Million | Rs23.71 Million | Rs-1.22 Million | Rs-2.90 Million | Rs5.44 Million |
| Investing Cash Flow | Rs-1.00 Million | Rs-229.00K | Rs-106.00K | Rs-699.00K | Rs-961.00K |
| Financing Cash Flow | Rs-45.00K | Rs-1.25 Million | Rs151.00K | Rs-58.00K | Rs-8.30 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | Rs3.54 Million |
| Depreciation | Rs3.80 Million | Rs3.99 Million | Rs4.29 Million | Rs4.28 Million | Rs4.12 Million |
| Change in Cash | Rs-20.28 Million | Rs22.46 Million | Rs-1.07 Million | Rs-2.96 Million | Rs1.84 Million |
Biofil Chemicals & Pharmaceuticals Limited Earnings History — EPS Actual vs. Analyst Estimates
Track Biofil Chemicals & Pharmaceuticals Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 30, 2025 | — | — | — |
| Nov 07, 2024 | — | — | — |